Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptides

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Molecular Biology

Background:

• Plasma high-density lipoprotein (HDL) cholesterol levels inversely correlate with atherosclerosis and cardiovascular disease (CVD) risk.
• HDL particles protect against atherosclerosis via reverse cholesterol transport and exhibit antioxidant, anti-inflammatory, antithrombotic, and antiapoptotic effects.
• These protective effects are mediated by HDL's lipid and protein components.

Purpose of the Study:

• To review current knowledge on the biological activities of major apolipoproteins and enzymes associated with HDL.
• To elucidate the mechanisms by which HDL components contribute to its antiatherogenic and cardioprotective functions.
• To inform therapeutic strategies aimed at enhancing HDL's antiatherogenic potency.

Main Methods:

• Literature review of studies on HDL components and their functions.
• Analysis of the roles of major apolipoproteins and enzymes in HDL's biological activities.
• Synthesis of current understanding of HDL's antiatherogenic and cardioprotective mechanisms.

Main Results:

• HDL particles exert cardioprotective effects through multiple mechanisms beyond reverse cholesterol transport.
• Specific HDL apolipoproteins and enzymes play crucial roles in mediating these beneficial effects.
• Understanding these individual component functions is key to harnessing HDL's therapeutic potential.

Conclusions:

• Elucidating the precise mechanisms of HDL components is vital for developing novel therapies against atherosclerosis and CVD.
• Targeting HDL's biological activities offers a promising strategy for cardiovascular disease prevention and treatment.
• Further research into HDL's multifaceted roles will advance cardiovascular medicine.